Skip to main content
Download PDF
  • Retraction Note
  • Open access
  • Published:

Retraction Note: The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine

Clinical Epigenetics volume 16, Article number: 100 (2024) Cite this article

The Original Article was published on 22 January 2024

Retraction Note: Clinical Epigenetics (2024) 16:16 https://doi.org/10.1186/s13148-024-01627-9


The Editor-in-Chief has retracted this article at the request of the corresponding author Lifang Huang because the authors did not have permission to publish the data reported. Lifang Huang, Yi Li and Xwen Tong agree with this retraction. Xia Mao, Mengyuan Li and Li Li have not responded to correspondence from the Publisher about this retraction.

Author information

Authors and Affiliations

  1. Renmin Hospital of Wuhan University, Wuhan, China

    Yi Li

  2. Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, 430030, Hubei, China

    Xia Mao, Mengyuan Li, Xiwen Tong & Lifang Huang

  3. Xinqiao Hospital of Army Medical University, Chongqing, China

    Li Li

Authors
  1. Yi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xia Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mengyuan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Li Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiwen Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lifang Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lifang Huang.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Y., Mao, X., Li, M. et al. Retraction Note: The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine. Clin Epigenet 16, 100 (2024). https://doi.org/10.1186/s13148-024-01715-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13148-024-01715-w

Clinical Epigenetics

ISSN: 1868-7083

Contact us